Mr. Hong is a graduate of Haverford College majoring in chemistry and minoring in economics. He has been involved in the research and streamlining of graphene synthetic methods for industrial production and energy applications. During the last few years, he has also been actively following the latest trends and developments in the biotechnology and energy sectors. Jeffrey started his scientific career with biomedical and biochemical research conducted at Northwestern University, University of Pennsylvania, and the National Institutes of Health.
Athena Bioventures invests in companies transforming the practice of medicine through scientific innovation. We are differentiated in that we closely work with scientists and physicians to maximize the potential of their invention and have them equitably share in the value of their creation.
Athena Bioventures invests in companies transforming the practice of medicine through scientific innovation. We are differentiated in that we closely work with scientists and physicians to maximize the potential of their invention and have them equitably share in the value of their creation.
Athena Bioventures invests in companies transforming the practice of medicine through scientific innovation. We are differentiated in that we closely work with scientists and physicians to maximize the potential of their invention and have them equitably share in the value of their creation.
